Lv1
30 积分 2021-07-21 加入
Emerging small-molecule AKR1C3 inhibitors development for cancer therapy: Progress from 2021 to 2025
1天前
待确认
Phosphorylation-Inducing Chimeric Small Molecules
6个月前
已完结
Targeting lysine acetylation readers and writers
6个月前
已完结
The cellular thermal shift assay for evaluating drug target interactions in cells
7个月前
已完结
Potent and selective aldo-keto reductase 1C3 (AKR1C3) inhibitors based on the benzoisoxazole moiety: application of a bioisosteric scaffold hopping approach to flufenamic acid
8个月前
已完结
皖公网安备34019202002308
